Putnam Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-123,800
Closed -$21.9M 943
2020
Q1
$21.9M Sell
123,800
-90,480
-42% -$17M 0.06% 206
2019
Q4
$41M Sell
214,280
-10,742
-5% -$1.94M 0.08% 188
2019
Q3
$37.9M Sell
225,022
-82,080
-27% -$13.4M 0.08% 193
2019
Q2
$51.4M Buy
307,102
+40,291
+15% +$5.58M 0.11% 170
2019
Q1
$39.1M Buy
266,811
+182,300
+216% +$26.4M 0.09% 181
2018
Q4
$11.3M Buy
84,511
+30,892
+58% +$5.06M 0.03% 301
2018
Q3
$10.2M Buy
53,619
+1,338
+3% +$246K 0.02% 388
2018
Q2
$8.72M Buy
52,281
+27,242
+109% +$4.37M 0.02% 401
2018
Q1
$4.21M Sell
25,039
-39,418
-61% -$6.61M 0.01% 544
2017
Q4
$10.5M Buy
64,457
+3,418
+6% +$613K 0.02% 375
2017
Q3
$12.5M Sell
61,039
-500
-0.8% -$116K 0.03% 347
2017
Q2
$15M Sell
61,539
-527,682
-90% -$124M 0.04% 311
2017
Q1
$141M Sell
589,221
-886,905
-60% -$207M 0.33% 85
2016
Q4
$310M Sell
1,476,126
-133,160
-8% -$27.6M 0.75% 26
2016
Q3
$371M Buy
1,609,286
+54,267
+3% +$13.3M 0.89% 25
2016
Q2
$359M Buy
1,555,019
+192,186
+14% +$44.3M 0.88% 20
2016
Q1
$365M Sell
1,362,833
-131,317
-9% -$37.6M 0.87% 20
2015
Q4
$467M Sell
1,494,150
-40,812
-3% -$12.2M 1.05% 16
2015
Q3
$417M Sell
1,534,962
-68,985
-4% -$21.2M 0.93% 16
2015
Q2
$487M Sell
1,603,947
-51,126
-3% -$15.2M 0.98% 15
2015
Q1
$493M Sell
1,655,073
-50,047
-3% -$14.3M 0.98% 13
2014
Q4
$439M Buy
1,705,120
+226,153
+15% +$56.5M 0.9% 15
2014
Q3
$357M Sell
1,478,967
-14,349
-1% -$3.21M 0.76% 25
2014
Q2
$333M Buy
1,493,316
+47,258
+3% +$9.78M 0.72% 20
2014
Q1
$298M Sell
1,446,058
-247,784
-15% -$49.1M 0.67% 34
2013
Q4
$285M Sell
1,693,842
-29,055
-2% -$4.54M 0.68% 34
2013
Q3
$248M Buy
1,722,897
+363,554
+27% +$48.4M 0.66% 33
2013
Q2
$172M Buy
+1,359,343
New +$154M 0.5% 47

Other funds holding AGN

Putnam Investments's AGN Position: Q2 2020 in Review

Putnam Investments sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 123,800 shares — an estimated $21.9M sold.

Putnam Investments first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $493M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Putnam Investments reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Putnam Investments sold 123,800 Allergan plc shares in Q2 2020, an estimated $21.9M.
  • Putnam Investments first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Putnam Investments's Allergan plc position peaked at $493M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Putnam Investments's 13F filing for Q2 2020, filed 14 Aug 2020.